Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

Overview of attention for article published in New England Journal of Medicine, August 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 4 posts from 4 blogs.

The integrin superfamily consists of 30 proteins that promote cell-cell or cell-matrix interactions. The name integrins …

NEJM 22 Aug 2013 Vol 369 699 Vedolizumab. What a name for an important new drug. Just remember the vedo bit and the fact…

The results from two phase 3 studies evaluating vedolizumab for the treatment of ulcerative colitis and Crohn's disease have…

A friend of mine, who has spent 15 years dealing with the ebbs and flows of ulcerative colitis (UC), is the kind of patient who…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.